Medical Device Export: Singapore vs EU — Tender Compliance Comparison for Chinese OEMs

This article is available in full Chinese at /zh/blog/medical-device-export-singapore-eu-comparison.

Singapore and the European Union represent the two most strategic market entries for Chinese medical device manufacturers going global. Singapore serves as the APAC bridgehead — with relatively fast HSA registration, a transparent GeBIZ procurement platform, and a regulatory framework that signals credibility across Southeast Asia. The EU offers the world's largest single medical device market, where MDR certification is the highest-value regulatory passport available.

This article provides a structured, side-by-side comparison across four critical dimensions: registration and market access (HSA vs EU MDR classification systems, registration timelines, local representative requirements, clinical data expectations, and cost ranges), procurement platforms (GeBIZ vs TED entry points, document languages, bidding cycles, digitization levels, and transparency), tender compliance requirements (HSA product registration numbers and NHG/ALPS evaluation standards vs MDR declarations of conformity, notified body certificates, and UDI-DI), and evaluation logic (Singapore's technical-plus-price scoring vs the EU's Most Economically Advantageous Tender principle with whole-life-cycle costing).

We also document the most common disqualification pitfalls Chinese manufacturers encounter in each market — three specific traps in Singapore and three in the EU — drawn from analysis of 30+ live tender submissions. Read the full article in Chinese, explore Orbid AI to see how AI automates multi-market compliance, or book a demo with a real tender document. Try it live at orbid.dev.